APOE and Alzheimer disease: Recent studies identified AD subtypes based on the large‐scale CSF proteomic analysis combining conventional markers, apolipoprotein E (APOE) variants, rare mutations, markers for vascular damage, patterns of cortical atrophy, and neuropathological characteristics7, 8 which provided significant insight into biological processes involved in AD.